Overview

Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study will be conducted to compare the pharmacokinetics of Lacosamide (LCM) following a single 30-minute or 60-minute iv infusion of LCM 200 mg with those following a single oral dose of LCM 200 mg in healthy Japanese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
UCB Pharma SA
Treatments:
Lacosamide